Physician profile
Christopher C Johnson
NPI 1215952247
$545.85
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $15.36 · 2022: $102 · 2023: $170 · 2024: $44.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $167.11 | 2019-2024 | Erleada, Akeega |
| Novartis Pharmaceuticals Corporation | $93.16 | 2019 | |
| Abiomed | $56.66 | 2022 | |
| Kestra Medical Technology Services, INC. | $44.48 | 2023 | Assure Wcd |
| Heartflow, INC. | $36.49 | 2023 | Ffrct |
| Atricure, INC. | $28.10 | 2023 | |
| Amgen INC. | $27.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.33 | 2022 | |
| Pfizer INC. | $19.35 | 2023 | |
| Boston Scientific Corporation | $18.73 | 2019 | |
| Merck Sharp & Dohme LLC | $17.26 | 2024 | Verquvo |
| Scpharmaceuticals INC. | $13.51 | 2023 | |
| Cardiovascular Systems INC. | $3.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.